Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials

p53, encoded by the tumor suppressor gene TP53, is one of the most important tumor suppressor factors in vivo and can be negatively regulated by MDM2 through p53–MDM2 negative feedback loop. Abnormal p53 can be observed in almost all tumors, mainly including p53 mutation and functional inactivation....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Haohao, Gao, Hui, Ji, Yingying, Zhou, Qin, Du, Zhiqiang, Tian, Lin, Jiang, Ying, Yao, Kun, Zhou, Zhenhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277894/
https://www.ncbi.nlm.nih.gov/pubmed/35831864
http://dx.doi.org/10.1186/s13045-022-01314-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277894/
https://www.ncbi.nlm.nih.gov/pubmed/35831864
http://dx.doi.org/10.1186/s13045-022-01314-3

Ejemplares similares